The association of autoimmune bullous diseases (i.e., bullous pemphigoid, linear IgA disease, mucous membrane pemphigoid and IgA pemphigus) and inflammatory bowel disease, namely ulcerative colitis and Crohn's disease has formerly been reported. However, to our knowledge, we report herein the first case of lymphocytic colitis with concomitant bullous pemphigoid.
INTRODUCTION
Bullous pemphigoid (BP) is the most common autoimmune bullous disease in elderly patients.
BP is associated with immunoglobulin (Ig) G tissue-bound and circulating autoantibodies which target hemidesmosomal proteins of the dermal-epidermal junction, named BP 180 (collagen type XVII) and BP 230. The disorder usually presents with generalized tense blisters or crusts, urticarial plaques, and prurigo-like eczematous lesions and is accompanied by severe pruritus [1] .
Lymphocytic colitis is an intestinal disorder which manifests as watery diarrhea. As a subset of microscopic colitis the macroscopic aspects of the colon mucosa on endoscopy remain unsuspicious, while histology reveals increased infiltrates of lymphocytes, plasma cells and eosinophils in the epithelium and lamina propria, respectively. The etiology is unknown, but auto-immunity is suggested [2, 3] .
Both entities, namely BP and lymphocytic colitis, occurring temporarily concomitant have not been described so far.
CASE REPORT
A 75-year-old female presented with a recent onset of itchy erythematous plaques with erosions and few blisters particularly on the Meanwhile, gastroenterological examinations were performed to clarify the cause of her chronic diarrhea. On endoscopy, the colonic mucosa seemed to be normal, but biopsy samples from various sites of the colon revealed diffuse infiltrates of lymphocytes, while cryptal architecture remained regular (Fig. 1) . Unfortunately, no direct or indirect IF for immunoglobulins was performed on colonic epithelium. These findings were diagnostic of lymphocytic colitis.
The patient was started on a therapy with low-dose systemic corticosteroid (methylprednisolone, initially 30 mg/day) and high-potency topical corticosteroids. Soon after partial remission was achieved on tempering doses of methylprednisolone, therapy was switched to oral budesonide, which is known to be effective at the side of the inflamed bowel. During the further course of 6 weeks, only a premonitory erythematous plaque on the forearm remained, while the frequency of diarrhea decreased significantly.
Informed consent was obtained from the patient for being included in this case report.
DISCUSSION
BP in patients with underlying inflammatory bowel disease (IBD) is relatively rare and has especially been reported for ulcerative colitis (UC) and Crohn's disease (CD). Shipmann et al. [4] reported on 19 patients with UC plus BP and two patients having CD and BP in his review of literature. In almost all cases the onset of intestinal symptoms preceded the first skin eruptions for 6 months to 23 years in UC and 1 or 2 years in CD [4] . Of note, the time span between CD and the onset of all bullous skin disease was shorter than for the majority of cases of UC. The association between IBD and autoimmune blistering diseases was overall more common for linear IgA disease (LAD 25 cases) than for BP [4] .
In a recent case series, only one patient with UC and concomitant BP was detected, while two had LAD or IgA pemphigus, respectively, and one had mucous membrane pemphigoid (MMP) [6] . To date, only one case of LAD in a 66-year-old female with lymphocytic colitis has been reported [3] . In our case, the subsequent occurrence of BP in preexisting enteropathy could certainly be coincidental. However, the rising gut symptoms immediately before the first skin eruption favor the hypothesis that both conditions might be related.
As a possible pathogenetic mechanism for the co-incidence of IBD and BP, a steadily autoimmune response against the denuded proteins of the inflamed colonic epithelium at the BMZ can be assumed. In the course of months or even years, intraand inter-molecular epitope-spreading phenomena might occur due to uncovered new protein components, explaining the cross-reactivity of autoantibodies with different exposed antigens.
Otherwise, preformed autoantibodies targeting similar or identical structural protein in colonic and skin epithelium can derive from a formerly non-pathogenic antibodies fraction following the same process [5] [6] [7] .
Firm evidence of a cross-reactivity of autoantibodies between colonic and skin epithelial antigens has been proven in dermatitis herpetiformis, where immune complexes containing IgA and epidermal transglutaminase as well as autoantibodies against endomysium, tissue transglutaminase and epidermal transglutaminase are responsible for clinical signs [8] . Equally, it has been described in patients with epidermolysis bullosa acquisita, where IgG autoantibodies to type VII collagen react upon IF with colonic BMZ [6] . These autoantibodies could be also detected by ELISA and immunoblot analysis in sera from patients with CD and UC, respectively [7] . Moreover, demonstration of positive IF in the gut in two cases of LAD and CD substantiate this conclusion [4] .
Possible antigen proteins expressed likewise in the gut and skin are BP180, desmoglein-1, type VII collagen, and plectin. The latter is co-localized and structural similar to BP230, both linking the hemidesmosome to the cellular cytoskeleton [6, 7] . 
